drugset / Trial / NCT03070847
Low vs. Very Low Dose of Prophylactic Tranexamic Acid for Bleeding Reduction During Rhinoplasty
RandomizedParallel-groupTriple-blindSupportive care
Summary
The purpose of this study is to determine whether very low dose of preoperative tranexamic acid (5mg/kg) is as effective as low dose (10mg/kg) for intraoperational bleeding reduction in patients undergoing elective rhinoplasty surgery.
Timeline
- Start
- 2017-03-01
- Primary completion
- 2019-03
- Completion
- 2019-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tranexamic Acid | Small molecule | 5 mg/kg | Intravenous |
| Comparator | Tranexamic Acid | Small molecule | 10 mg/kg | Intravenous |
| Background | sodium chloride | Unknown | — | — |
Indications
No indication recorded.